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Peripheral interventionStarting with the 50-year-old pioneering work of Dotter,
Gruntzig, and others, the role of endovascular revasculariza-
tion has steadily expanded in the treatment of peripheral
arterial disease.1 Endovascular techniques that include bal-
loon expandable stents, self-expanding stents, and stent grafts
are applied everywhere in peripheral arterial tree but are
actually preferred in the management of aorto-iliac athero-
sclerotic disease.2 The immediate success rates with aorto-
iliac endovascular therapy and especially with iliac stenting
are over 95% with complication rates of less than 5% and the
annual restenosis rates of about 10%. Hence, iliac artery
lesions are routinely treated with ‘‘stent ﬁrst strategy’’.
However, not just the patient-related factors but also the
lesion complexities related to the length, location, and total
occlusion versus stenosis as deﬁned by angiographic TASC
criteria affect endovascular outcomes.3 TASC-based guide-
lines exist, guiding the decision-making and the appropriate-
ness of stenting versus surgery and medical therapy.
Predictably, the usual indications for lower extremity revas-
cularization including the aorto-iliac revascularization are
limited to symptomatic conditions like lifestyle limiting
claudication, rest pain, tissue loss, and less commonly,
spontaneous distal embolization. However, due to the excel-
lent results with short iliac stenosis, endovascular therapy is
applied as a ﬁrst line approach instead of trying initial trials of
medical therapy and rehabilitation exercise as opposed to the
approach for below the inguinal ligament arteries.
The iliac intervention technique is essentially the same for
de novo lesions and restenotic lesions. Initial angiography that§ This editorial is pertaining to the article: Contralateral approach to 
aortic bifurcation.include angulated views of the aortoiliac region and complete
run-off study to the feet is necessary; otherwise, the previously
existing disease may be indistinguishable from periprocedural
embolic events.
The initial access site is based on the operator preference
but some generalizations can be made depending on the
location of the lesion and stenotic versus occlusive lesion
types (Fig. 1). The preferred access for a common iliac stenosis
is retrograde ipsilateral femoral access approach. The ipsilat-
eral approach allows adequate support for passage of wires
and sheaths across often noncompliant and calciﬁed vessels.
For negotiating an occluded common iliac through ipsilateral
access, contralateral femoral artery is also accessed and used
to pass an additional catheter for complete angiography and to
have access in case of contralateral vascular injury.
Ipsilateral retrograde common femoral and the adjacent
external iliac are, sometimes, too diseased for sheath
placement. This may be due to an external iliac occlusion
that extends up to the common femoral junction leaving no
room for an ipsilateral sheath. In such situations, contralateral
femoral access with cross-over across the aortic bifurcation
would allow access to external iliac lesions. For distal external
iliac lesions, in particular, this would mean more complete
treatment up to the junction of common femoral artery that
may not be possible with an ipsilateral retrograde femoral
access.
Totally occluded vessels have slightly different access
approach compared to stenotic vessels in the absence of
occlusive disease. This is because passage of wires across the
totally occluded vessels is challenging and may require greater
catheter support. Instead of using 0.035 in. steerable and
ﬂexible guide wires through a low proﬁle catheter as done with
stenotic vessels, hydrophilic wires with hydrophilic low proﬁle
catheters are preferred when crossing 100% blocked vessels.
The wires in occluded lesions often travel subintimally and
usually need to be prolapsed to dissect long distances
of subintimal space before the wires are completely across
the length of the occluded segments. The wires are then
placed back in the true lumen either by the mere wire tipiliac artery recanalization with kissing nitinol stents present in the
Fig. 1 – Selection of access site for endovascular treatment of iliac artery.
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During subintimal passage, more supportive catheters and
wires are needed for greater force required for crossing often
calciﬁed, hard, and chronic lesions.
Ipsilateral retrograde femoral access may be chosen when
approaching occluded common iliac lesions but in case of false
lumen entry into the aorta, re-entry into aortic true lumen may
be more difﬁcult from retrograde than wire passage from the
antegrade contralateral approach.2 Occluded common iliac,
hence, may be better approached from contralateral femoral
access as long as there is a proximal iliac stump allowing
crossover catheter access to hook the proximal occluded
vessel for catheter seating and guide wire passage. This is
noted in this issue of the journal by the authors of the
manuscript ‘‘Contralateral approach to iliac artery recanaliza-
tion with kissing nitinol stents present in the aortic bifurca-
tion’’. The authors appear to choose this approach both
because of involvement of external iliac and the potentially
easier wire passage of an occluded iliac from the antegrade
approach. As discussed by these authors, brachial access has
higher aortic arch complication risk but in yet another scenario
of iliac disease, that is, if the common iliac is ﬂush occluded at
the ostium, left brachial access may be preferred as the
contralateral access needs an iliac stump for catheter support.
This is still a challenging scenario however as obtaining wire
access to the true lumen when crossing a ﬂush iliac occlusion
is tough and complications can occur not only at the aortic
arch level but also at the iliac level and a perforation here
would need emergent covered stent placement after place-
ment of an occlusive proximal aortic compliant balloon to
control the bleeding from the perforation. Also, left brachial is
more favorable than the right brachial as the site of origin of
left subclavian is more distal on the aortic arch allowing a less
tortuous course to the descending aorta compared to the
sharply angulated course from the right arm to the lowerextremities. Popliteal, pedal artery, or radial access sites are
rarely used for iliac intervention.
Self-expanding stents are preferred in iliac circulation
because of size discrepancies between common iliac and
external iliac and these stents are then sized to the larger
diameter vessel segment. Self-expanding helps because of the
large size discrepancies encountered in proximal and distal
stent landing zones and also because of ectatic disease.
However, balloon expandable stents are preferred for aorto-
iliac lesions. Kissing stent technique is often applied at the
aorto-iliac site as noted by the authors of the manuscript
‘‘Contralateral approach aortic bifurcation’’. As opposed to
these authors strategy, balloon expandable stents are pre-
ferred in ostial iliac lesions because of the precise landing zone
and higher radial strength characteristics of balloon expand-
able stents that are useful in the calciﬁed aortic bifurcation
lesions that have a high recoil and need precise deployment.
The authors used self-expanding stents to rebuild the aortic
carina in the absence of any contraindication to such
approach. Rebuilding the aortic carina superiorly as noted
by these authors is customary when treating distal aortic
bifurcation disease. Often, kissing balloon angioplasty or
kissing stenting strategy is applied for bilateral ostial iliac
disease but when stenting unilateral disease of distal aortic
bifurcation, contralateral protection with a balloon is no longer
considered necessary as noted on recent studies.2
In general, for de novo iliac stenoses, primary stenting is
favored but provisional stenting is acceptable (stenting is
mandatory if ﬂow limiting dissection, residual stenosis of over
30% or systolic gradient >10 mm of Hg is seen after balloon
angioplasty).
After lower extremity percutaneous revascularization,
objective follow-up of arterial patency using anatomic imaging
or physiological assessment is recommended even though
less rigorous follow-up with non-invasive studies is needed
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the inguinal ligament treated arteries. For this purpose, Duplex
imaging of the iliac after 3 months of intervention is a
commonly used non-invasive study. Restenosis is deﬁned as
angiographic 50% reduction in diameter as compared to the de
novo stenosis that is also often deﬁned as 50% diameter
narrowing with a catheter measured mean gradient of 5–
10 mm of Hg. Doppler criteria for restenosis include a doubling
of velocity within the iliac stent along with drop in Ankle
Brachial Index by at least 0.1. During follow-up, primary
patency is deﬁned by the treated vessels without restenosis
and repeat revascularization while secondary patency refers
to the target vessels that become totally occluded and are
reopened by repeat revascularization.
However, the detection of restenosis does not automati-
cally lead to angiography and possible treatment with
endovascular approach. Symptoms are often required for
re-intervention.2 However, the rapidity of restenosis devel-
opment and restenosis of greater than 70% may trigger
treatment even in absence of symptoms, especially in
patients with prior treatment for critical limb ischemia. Such
restenosis detected non-invasively is often treated with
percutaneous intervention to avoid progression to total
occlusion. Total stent occlusion is associated with lower
procedural success rate compared to in-stent restenosis due
to difﬁculty with wire passage.2
The risk of restenosis in the iliac artery is the lowest among
any artery in the lower extremity. Long-term patency rates
show 3 years primary patency of 59–86% and 5 years primary
patency of 49–75%.4 The predictors of higher risk of restenosis
include female gender, angiographically complex disease,
diabetes mellitus, younger age, poor outﬂow, occlusion versus
stenosis, and external iliac artery involvement.2,5
The optimal treatment of instent restenosis in iliac arteries
is not known.4 The mechanism of iliac restenosis is not
dissimilar from restenosis elsewhere in arterial tree, which isFig. 2 – Treatment decisinﬂammatory response leading to neointimal tissue prolifera-
tion and tissue ingrowth causing a reduction of lumen
diameter. Various and diverse treatment modalities like repeat
balloon angioplasty, stents (balloon expandable, self-expanding
or covered), cutting balloon angioplasty, atherectomy and more
recently drug coated balloons, and drug stents have been tried
(Fig. 2). No single technique is the gold standard but as with de
novo lesions in iliac arteries, endovascular interventional
techniques are more effective in treating restenotic lesions in
the iliac than for other lower extremity arteries.2,5 Both balloon
angioplasty only approaches with provisional stenting and
primary stenting have good outcomes in follow-up studies after
treatment of iliac restenosis but most data favor primary
stenting, that is, all lesions would be stented regardless of
angioplasty result.4 Studies of covered stents in iliac restenosis
show results that are even better than uncovered stent results
but covered stents have drawbacks like reduced deliverability
and risk of covering branch vessels and collaterals.4,5
Hence, the initial approach for a restenotic iliac stent is
repeat stenting with primary stenting approach even though
balloon/cutting balloon angioplasty with provisional stenting
is acceptable. These interventional modalities provide good
results in studies with medium-term or long-term follow-up.4
Likewise, the covered stents have excellent results for de novo
iliac lesions but for restenotic lesions, comparisons with
uncovered stents are limited by the small number of available
studies but do favor covered stent approach.4,5 Atherectomy
and laser therapies are not applied commonly in the iliac
arteries as opposed to the way that they are frequently used in
the restenosis of infra-inguinal arteries. Similarly, drug-coated
balloons that have had encouraging results in below the
inguinal ligament circulation, have been tested in only small
studies of iliac restenosis with the 2-year results in a small trial
showing hundred percent patency.5
In conclusion, iliac artery stenosis and restenosis can be
treated in a variety of ways by endovascular therapy. Theions in iliac lesions.
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strated that the endovascular approach is not only a good
alternative to surgical bypass but also the preferred revascu-
larization approach in most clinical situations.
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